Urgent

High-risk bifascicular / trifascicular block

Advanced conduction disease · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Combined conduction block (e.g. RBBB with fascicular block, +/- first-degree AV block) carrying risk of progression to complete heart block, especially if symptomatic.

Red flags

  • Syncope or presyncope
  • Alternating bundle branch block
  • Progression to complete block
  • Concurrent MI

Assessment

Differential diagnosis

  • Isolated bundle branch block
  • Complete heart block
  • Hyperkalaemia
  • Drug effect
  • Cardiac sarcoid/amyloid

Investigations

  • 12-lead ECG and telemetry
  • Electrolytes including potassium
  • Troponin to exclude ischaemia
  • Echocardiography

Management

  • Attach continuous cardiac monitoring
  • Assess for syncope, ischaemia and reversible causes
  • Stop AV nodal blocking drugs if implicated
  • Have transcutaneous pacing available for symptomatic bradycardia
  • Correct electrolytes and treat ischaemia
  • Refer for pacing assessment/EP study

Drugs & doses

Atropine (anticholinergic) - 500 mcg IV for symptomatic bradycardia (limited efficacy infranodal)
Isoprenaline/adrenaline infusion (chronotrope) - bridge if unstable
Avoid additional AV nodal blockers

Disposition

Admit with telemetry for pacing assessment.

Complications & pitfalls

  • Complete heart block
  • Asystole
  • Syncopal injury

Exam pearls

  • Atropine is often ineffective for infranodal block
  • Syncope with bifascicular block warrants pacing evaluation
  • Alternating BBB is a strong pacing indication

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.